EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Pharma's Medical Affairs Bridge: From Field Insights and Stakeholder Needs to Global Scientific Strategy
Medical Affairs has evolved from being primarily a supportive and educational function to becoming a strong strategic partner earlier on Through ongoi...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
How Decentralized Clinical Trials Are Changing U.S. Research
For most of its history the American clinical trial has been built around a single location the research site Participants were expected to travel often repeatedly to an academic medical center or specialist clinic for screening dosing blood draws and questionnaires That model produced rigorous science but it also produced familiar frustrations for pharmaceutical sponsors including slow recruitmen...
-
Techno Trends
Lilly’s Jaypirca Gains FDA Approval for First-Line CLL/SLL Treatment
Eli Lilly and Company has received approval from the US Food and Drug Administration FDA for an additional indication for Jaypirca pirtobrutinib in adults with previously untreated chronic lymphocytic leukaemia CLL or small lymphocytic lymphoma SLL without a known p deletion The approval enables Jaypirca to be used as a firstline treatment
-
Projects
Genentech Begins US$750 Million Expansion of Oregon Manufacturing Facility
Genentech a member of the Roche Group has started construction on a US million expansion of its manufacturing facility in Hillsboro Oregon The squarefoot project will double the existing sites footprint and increase US production capacity for advanced drug delivery devices
-
Research Insights
Identification of flavonoids from natural products against hyperlipidaemia through computational approaches
Over the centuries hyperlipidaemia has been recognised as a major risk factor contributing to cardiovascular disease CVD Current research increasingly explores natural compounds such as flavonoids for their potential lipidlowering effects This study evaluated pharmacological potential
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
What Challenges and Opportunities Define Modern CNS Drug Development?
Kate Williamson
The landscape of modern CNS drug development is marked by challenges including CNS complexity, BBB limitations, disease heterogeneity, biomarker scarcity, safety concerns, limited treatments, regulato...
-
2
U.S. Pharmaceutical Outsourcing: CRO, CDMO and Contract Manufacturing Strategies
Sarah Richards
U.S. pharmaceutical companies increasingly rely on external partners to move drugs from lab to market. This article explains how CROs, CDMOs and contract manufacturers differ, compares contract manufa...
-
3
Advancements in Vaccine Development: A Focus on Immunization Strategies
Kate Williamson
Recent breakthroughs in vaccine development are shaping the future of immunization. mRNA vaccines like Pfizer-BioNTech and Moderna revolutionize the field by instructing cells to produce viral protein...
-
4
Generative AI in Clinical Operations: Optimizing Protocol Development and Site Selection
Lakshmi
Protocol complexity and underperforming investigator sites remain two of the largest controllable drivers of cost and delay in pharmaceutical development. Generative AI offers a practical route to bot...
-
5
Adaptive Trial Designs: Enhancing Speed and Decision-Making in Clinical Development
Lakshmi
Adaptive trial designs let pharmaceutical sponsors modify a study while it runs, according to rules written before the first patient enrolls. Used well, they stop failing programs sooner, concentrate...
press releasesRead more...
Global Pharmaceutical Company Commits to a Dual-Site Deal with AGC Biologics Exceeding €0.5 Billion
AGC Biologics has expanded its existing longterm manufacturing agreement with a global pharmaceutical company adding a second supply node at the CDMOs Copenhagen facility The expansion which builds on the existing agreement anchored at AGC Biologics
Newleos Announces $15.5 Million NIH Grant and Receipt of FDA Fast Track Designation for NTX-2001 to Treat Substance Use Disorders
Newleos Therapeutics Inc a clinicalstage biotechnology company developing innovative treatments for neuropsychiatric disorders today announced that the National Institute on Drug Abuse NIDA part of the National Institutes of Health NIH has awarded the company up to million to fund the development o...
Guardian Pharmacy Services Acquires Van’s Institutional Pharmacy, Expanding Footprint in Tennessee and Kentucky
Guardian Pharmacy Services Inc one of the nations largest and most innovative longterm care LTC pharmacy services companies today announced the acquisition of Vans Institutional Pharmacy an LTC pharmacy based in Martin Tenn The addition grows Guardians Tennessee operations to five pharmacies
Immunome Announces EMA Validation of Marketing Authorization Application for Varegacestat for the Treatment of Adults with Desmoid Tumors
Immunome Inc a clinicalstage targeted oncology company committed to developing firstinclass and bestinclass targeted cancer therapies today announced that the European Medicines Agency EMA has validated the Marketing Authorization Application MAA for varegacestat an investigational oral oncedaily ga...
Events Read more...
02 - 04
Nov 2026Pharma Forum EMEA 2026
Dom Pedro Lisboa Hotel, Lisbon...
02 - 04
Nov 2026Cancer R&D 2026
Houston, TX, USA
03 - 05
Nov 202610th Dermatology Drug Development
Boston, Massachusetts at The C...
03 - 04
Nov 2026PDA Aseptic Processing of Biopharma Conference
Sheraton Grand Incheon Hotel,...
04 - 05
Nov 2026Advanced Therapies USA
Hynes Convention Center, Bosto...
05 - 05
Nov 2026PDA Contamination Control Strategy Workshop
Sheraton Grand Incheon Hotel,...
09 - 11
Nov 202611th Microbiome Movement USA Summit
The Colonnade Hotel, Boston, M...
10 - 11
Nov 2026Extractables & Leachables Europe
Parkhotel Schӧnbrunn, Vienna,...
LATEST NEWSRead more...
Moleculent Introduces Glimt, the First Automated Instrument for Functional Profiling of Cell-Cell Interactions in Human Tissue
Moleculent AB the life sciences technology company pioneering functional profiling today announced Glimt an automated platform that detects cellcell interactions directly in formalinfixed paraffinembedded FFPE tissue The Glimt platform is now available to selected academic
Rhythm Pharmaceuticals and LG Chem Enter into Amendment to Bivamelagon Exclusive License Agreement
Rhythm Pharmaceuticals Inc announced an amendment to the global exclusive license agreement with LG Chem Ltd for bivamelagon an investigational oral smallmolecule melanocortin receptor MCR agonist The Company also announced a fiveyear term loan facility led by KKR
SCIEX Launches LeadScape Compatible with SCIEX OS Software to Accelerate High-Throughput Drug Candidate Evaluation
SCIEX a Danaher company and leader in life science analytical technologies today announced the launch of LeadScape compatible with SCIEX OS software a new highthroughput workflow solution that accelerates drug candidate evaluation Developed by Sound Analytics the software
Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
Denali Therapeutics Inc announced that AVLAYAH tividenofusp alfaeknm has been recognized as the Best Biotechnology Product of by The Galien Foundation AVLAYAH is the first biologic approved by the US Food and Drug Administration FDA that is specifically designed to cross the bloodbrain barrier and...
Doximity Launches DoseCheck to Catch Dangerous AI Drug Dosing Errors Before They Reach Doctors
Doximity Inc the leading digital platform for US medical professionals has launched DoseCheck a free additional safety layer in Doximity Ask that instantly checks every AIgenerated medication dosing claim against a structured drug database to reduce treatment
Celularity and Vesalius Longevity Labs Sign Exclusive Collaboration for Peptual® Peptide APIs Manufactured in the United States
Celularity Inc a longevityfocused regenerative and cellular medicine company and Vesalius Longevity Labs Inc Vesalius a leading global peptide and longevity brand today announced that they have entered into an exclusive manufacturing agreement to establish a dedicated firstofitskind US final stage
